This consultation closed on 1 November 2022
Consultation period
4 October 2022 to 1 November 2022

The APVMA is considering an application for the registration of the product Simodis Plinazolin Technology Insecticide, containing 100 g/L isocycloseram, as a dispersable concentrate (DC) formulation. The product is intended for the control of certain insect and mite pests in vegetables.

We invite comment from 4 October 2022 to 1 November 2022 on whether registration of the product should be granted.

The APVMA can consider comments relating to the legislative grounds, including:

  • occupational health and safety
  • public health
  • chemistry and manufacture
  • residues in food
  • environmental safety
  • trade
  • efficacy and target crop safety.

Download the Public Release Summary on the evaluation of Simodis Plinazolin Technology Insecticide.

For more information see page 26, APVMA Gazette No. 20, 4 October 2022.

Please note: submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential, or if the APVMA chooses at its discretion not to publish any submissions received (refer to the public consultation coversheet).

Please lodge your submission using the public consultation coversheet, which provides options for how your submission will be published.

Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.

Please send your written submission and coversheet by email or post to:

Email: enquiries@apvma.gov.au

Post:

Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001

Submissions received

The APVMA sought comments from interested stakeholders on isocycloseram in the product Simodis Plinazolin Technology Insecticide, in a consultation that closed on 1 November 2022.

No submissions were received. We have finalised registration of the product.

Consultation period
2022-10-04T12:00:00 - 2022-11-01T12:00:00
Content last updated:
Content last reviewed: